We are live on ! Find out more
GWM

Geneos Wealth Management Portfolio holdings

AUM $4.31B
1-Year Est. Return 18.36%
This Fund
S&P 500
This Quarter Est. Return
-11.63%
1 Year Est. Return
+18.36%
3 Year Est. Return
+53.76%
5 Year Est. Return
+60.8%
10 Year Est. Return
+204.74%
AUM
$1.35B
AUM Growth
-$150M
Cap. Flow
+$56.3M
Cap. Flow %
4.16%
Top 10 Hldgs %
19.09%
Holding
2,522
New
117
Increased
687
Reduced
642
Closed
145

Sector Composition

Rank Sector Weight
1 Technology 5.94%
2 Energy 5.6%
3 Industrials 5.47%
4 Healthcare 5.28%
5 Financials 5.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EZU icon
501
iShare MSCI Eurozone ETF
EZU
$9.73B
$282K 0.02%
8,086
+8,043
+18,705% +$300K
MUB icon
502
iShares National Muni Bond ETF
MUB
$45.2B
$282K 0.02%
2,596
+353
+16% +$38K
CLR
503
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$282K 0.02%
7,089
-480
-6% -$24.5K
BCE icon
504
BCE
BCE
$20.3B
$280K 0.02%
7,103
+5,664
+394% +$232K
EVRG icon
505
Evergy
EVRG
$19.1B
$280K 0.02%
4,963
+3
+0.1% +$173
LNG icon
506
Cheniere Energy
LNG
$53.9B
$280K 0.02%
4,856
+95
+2% +$5.85K
FIS icon
507
Fidelity National Information Services
FIS
$23.3B
$278K 0.02%
2,759
+8
+0.3% +$834
GAA icon
508
Cambria Global Asset Allocation ETF
GAA
$72.2M
$277K 0.02%
11,231
-255
-2% -$6.55K
LGIH icon
509
LGI Homes
LGIH
$1.3B
$275K 0.02%
5,951
RPG icon
510
Invesco S&P 500 Pure Growth ETF
RPG
$2.04B
$275K 0.02%
13,965
-208,020
-94% -$4.47M
IJT icon
511
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.35B
$271K 0.02%
3,388
-1,574
-32% -$140K
DEO icon
512
Diageo
DEO
$49.3B
$270K 0.02%
1,913
+36
+2% +$5.06K
VPL icon
513
Vanguard FTSE Pacific ETF
VPL
$8.12B
$269K 0.02%
4,429
-741
-14% -$48K
KBWD icon
514
Invesco KBW High Dividend Yield Financial ETF
KBWD
$415M
$268K 0.02%
13,451
-285
-2% -$6.14K
BHP icon
515
BHP
BHP
$212B
$267K 0.02%
6,260
-274
-4% -$11.5K
DG icon
516
Dollar General
DG
$28.3B
$267K 0.02%
2,495
-149
-6% -$16.1K
RITM icon
517
Rithm Capital
RITM
$5.62B
$265K 0.02%
18,312
+675
+4% +$11.4K
VOT icon
518
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.6B
$264K 0.02%
2,236
NJR icon
519
New Jersey Resources
NJR
$5.86B
$263K 0.02%
5,804
NTR icon
520
Nutrien
NTR
$31.6B
$263K 0.02%
5,687
-817
-13% -$42.6K
DNOW icon
521
DNOW Inc
DNOW
$2.6B
$262K 0.02%
22,926
BUD icon
522
AB InBev
BUD
$166B
$260K 0.02%
3,962
+528
+15% +$40.4K
DIV icon
523
Global X SuperDividend US ETF
DIV
$783M
$256K 0.02%
11,516
+4
+0% +$97
MPT
524
Medical Properties Trust
MPT
$2.74B
$255K 0.02%
15,932
+1,691
+12% +$26.8K
PBCT
525
DELISTED
People's United Financial Inc
PBCT
$254K 0.02%
17,811
-4,866
-21% -$77K

Similar funds

Geneos Wealth Management's Q4 2018 Portfolio in Review

As of Q4 2018, Geneos Wealth Management held 2,522 positions worth $1.35B, down 10% from $1.5B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Geneos Wealth Management deployed $56.3M of net new capital in Q4 2018, opening 117 new positions and adding to 687 existing holdings. Its largest new stake was Vanguard Russell 1000 Growth ETF: 26,240 shares worth $872K.

By sector, the portfolio is most concentrated in Technology at 5.9% of assets, down from 6.5% a quarter earlier, followed by Energy and Industrials.

On the sell side, the largest reduction was iShares Core S&P Mid-Cap ETF, an estimated $9.44M trimmed.

  • Geneos Wealth Management's largest Q4 2018 buy was Vanguard Russell 1000 Growth ETF: 26,240 shares worth $872K.
  • Geneos Wealth Management added most to iShares Russell 1000 ETF in Q4 2018, an estimated $16M increase.
  • Geneos Wealth Management's biggest Q4 2018 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $9.44M.
  • Geneos Wealth Management fully exited ProShares Ultra Consumer Discretionary in Q4 2018, selling an estimated $4.08M.
  • Geneos Wealth Management's ten largest holdings make up 19% of its $1.35B portfolio in Q4 2018.
  • Geneos Wealth Management opened 117 new positions and closed 145 in Q4 2018.
  • Geneos Wealth Management's portfolio value fell 10% quarter-over-quarter to $1.35B.

Based on Geneos Wealth Management's 13F filing for Q4 2018, filed 7 Sep 2021.